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The aim of this study was to describe the population pharmacokinetics of mavacoxib in African grey 
parrots (AGP). AGP were administered a single dose of mavacoxib (4 mg/kg BW) orally. Blood samples 
were drawn at several time-points after administration. Quantification of mavacoxib in plasma of AGP 
was carried out using a validated high-performance liquid chromatography-tandem mass 
spectrometry (HPLC-MS/MS) method (Dhondt et al. 2017). Data was processed using the nonlinear 
mixed effects (NLME) approach. Similarly as in cockatiels (Nymphicus hollandicus) (Dhondt et al., 
2017), mavacoxib is also in AGP characterized by a prolonged elimination half-life (T1/2el= 115.89h, 
coefficient of variation (CV)%= 7.87). Mavacoxib was characterized by a high volume of distribution 
(3.29 L/kg, 7.05%) and a remarkably low clearance (0.020 L/h.kg, 10.84%). Based on the presented 
results, a less frequent dosing of mavacoxib is proposed compared to other frequently used NSAIDs in 
avian practice. However, pharmacodynamics and safety studies are necessary to further investigate 
the use of mavacoxib in AGP.  
